title: Proteomic identification of the cerebral cavernous malformation signaling complex.
abstract: Cerebral cavernous malformations (CCM) are sporadic or inherited vascular lesions of the central nervous system characterized by dilated, thin-walled, leaky vessels. Linkage studies have mapped autosomal dominant mutations to three loci: ccm1 (KRIT1), ccm2 (OSM), and ccm3 (PDCD10). All three proteins appear to be scaffolds or adaptor proteins, as no enzymatic function can be attributed to them. Our previous results demonstrated that OSM is a scaffold for the assembly of the GTPase Rac and the MAPK kinase kinase MEKK3, for the hyperosmotic stress-dependent activation of p38 MAPK. Herein, we show that the three CCM proteins are members of a larger signaling complex. To define this complex, epitope-tagged wild type OSM or OSM harboring the mutation of F217-->A, which renders the OSM phosphotyrosine binding (PTB) domain unable to bind KRIT1, were stably introduced into RAW264.7 mouse macrophages. FLAG-OSM or FLAG-OSMF217A and the associated complex members were purified by immunoprecipitation using anti-FLAG antibody. OSM binding partners were identified by gel-based methods combined with electrospray ionization-MS or by multidimensional protein identification technology (MudPIT). Previously identified proteins that associate with OSM including KRIT1, MEKK3, Rac, and the KRIT1-binding protein ICAP-1 were found in the immunoprecipitates. In addition, we show for the first time that PDCD10 binds to OSM and is found in cellular CCM complexes. Other prominent proteins that bound the CCM complex include EF1A1, RIN2, and tubulin, with each interaction disrupted with the OSMF217A mutant protein. We further show that PDCD10 binds phosphatidylinositol di- and triphosphates and OSM binds phosphatidylinositol monophosphates. The findings define the targeting of the CCM complex to membranes and to proteins regulating trafficking and the cytoskeleton.
authors: Department of Pharmacology and the Lineberger Comprehensive Cancer Center, School of Dentistry, University of North Carolina, Chapel Hill, CB #7365, Chapel Hill, North Carolina 27599-7365, USA.
authors: Thomas L
authors: TL
authors: Hilder
authors: Michael H
authors: MH
authors: Malone
authors: Sompop
authors: S
authors: Bencharit
authors: John
authors: J
authors: Colicelli
authors: Timothy A
authors: TA
authors: Haystead
authors: Gary L
authors: GL
authors: Johnson
authors: Christine C
authors: CC
authors: Wu
mesh_terms: D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000378:metabolism; D019556:COS Cells; D002522:Chlorocebus aethiops; D003599:Cytoskeleton / Q000378:metabolism; D020786:Hemangioma, Cavernous, Central Nervous System / Q000378:metabolism*; D006801:Humans; D047468:Immunoprecipitation; D048748:MAP Kinase Kinase Kinase 3 / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D010710:Phosphates / Q000737:chemistry; D010716:Phosphatidylinositols / Q000737:chemistry; D017434:Protein Structure, Tertiary; D040901:Proteomics / Q000379:methods*; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D015398:Signal Transduction; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods; D020744:rac GTP-Binding Proteins / Q000378:metabolism
chemical_list: D051017:Apoptosis Regulatory Proteins; D008565:Membrane Proteins; C495390:PDCD10 protein, human; D010710:Phosphates; D010716:Phosphatidylinositols; D011518:Proto-Oncogene Proteins; D048748:MAP Kinase Kinase Kinase 3; C482625:MAP3K3 protein, human; D020744:rac GTP-Binding Proteins